ADRA2C and glioblastoma: Finally, there was no relationship between ADRA2C expression level and prognosis of BLCA, BRCA, CESC, CHOL, COAD, DLBC, ESCA, esophageal adenocarcinoma (ESAD), GBM, HNSC, KICH, KIRC, LAML, LGG, LIHC, LUAD, LUSC, mesothelioma (MESO), oral squamous cell carcinoma (OSCC), OV, PAAD, PCPG, PRAD, READ, sarcoma (SARC), SKCM, STAD, TGCT, THCA, THYM, UCEC, and UCS.